Conning Inc’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-7,333
Closed -$588K 608
2016
Q4
$588K Buy
7,333
+190
+3% +$15.1K 0.02% 356
2016
Q3
$570K Buy
7,143
+390
+6% +$31.5K 0.02% 359
2016
Q2
$527K Buy
6,753
+20
+0.3% +$1.43K 0.02% 367
2016
Q1
$370K Buy
6,733
+120
+2% +$6.54K 0.02% 422
2015
Q4
$408K Sell
6,613
-390
-6% -$24.6K 0.02% 409
2015
Q3
$442K Sell
7,003
-700
-9% -$50K 0.02% 377
2015
Q2
$563K Sell
7,703
-180
-2% -$13K 0.02% 364
2015
Q1
$516K Sell
7,883
-120
-1% -$7.98K 0.02% 377
2014
Q4
$520K Sell
8,003
-260
-3% -$16.7K 0.03% 376
2014
Q3
$497K Sell
8,263
-330
-4% -$21.6K 0.03% 373
2014
Q2
$595K Sell
8,593
-570
-6% -$37K 0.03% 332
2014
Q1
$599K Buy
9,163
+560
+7% +$36.5K 0.04% 325
2013
Q4
$533K Buy
8,603
+1,530
+22% +$88.6K 0.03% 313
2013
Q3
$379K Buy
7,073
+70
+1% +$3.6K 0.03% 339
2013
Q2
$320K Buy
+7,003
New +$303K 0.03% 367

Other funds holding STJ

Conning Inc's STJ Position: Q1 2017 in Review

Conning Inc sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 7,333 shares — an estimated $588K sold.

Conning Inc first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $599K in Q1 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Conning Inc reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Conning Inc sold 7,333 St Jude Medical shares in Q1 2017, an estimated $588K.
  • Conning Inc first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Conning Inc's St Jude Medical position peaked at $599K in Q1 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Conning Inc's 13F filing for Q1 2017, filed 27 Apr 2017.